In patients with locally advanced rectal cancer who receive neoadjuvant therapy, radiation dose intensification improves pathologic complete response but leads to a small increase in acute toxicities.

The Chinorec trial reveals that combining Yervoy and Opdivo with chemoradiotherapy is safe for rectal cancer, though response rates remain unchanged.

Among patients with locally advanced rectal cancer, concurrent chemoradiotherapy did not significantly increase second pelvic malignancies compared to chemotherapy alone, but it did raise the risk for ...

After a stage 3b rectal cancer diagnosis, one patient endured radiation, chemotherapy, surgery, and complications, relying on resilience, advocacy and support.

Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...

The nonoperative regimen led to a 2-year total mesorectal excision (TME)-free survival of 57% in 63 evaluable patients, and a 2-year progression-free survival (PFS) of 84%. Almost all patients ...

Survival benefits of adjuvant chemotherapy after surgical resection of para-aortic lymph node metastasis from colorectal cancer: A multicenter retrospective study. Fruquintinib plus best supportive ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Learn what the American Cancer Society says about screening, early warning signs, and preventive steps, including lifestyle changes and how aspirin may help reduce your risk. Keep reading to know more ...

Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby — ...

Colorectal cancer is a common cancer in the United States. The National Cancer Institute estimates many diagnoses and deaths. The American Cancer Society gives guidelines for screening based on risk ...